Clearside Biomedical Stock (NASDAQ: CLSD) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 173.80K |
Day Range | - - - |
52 Wk Range | 0.65 - 2.12 |
Market Cap | $87.44M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 45 |
Short Interest | 0.32% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Clearside Biomedical (NASDAQ:CLSD) through any online brokerage.
Other companies in Clearside Biomedical’s space includes: Universe Pharmaceuticals (NASDAQ:UPC), SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Rani Therapeutics Hldgs (NASDAQ:RANI) and Marinus Pharma (NASDAQ:MRNS).
There is no analysis for Clearside Biomedical.
Clearside Biomedical has a consensus price target of $5.13.
The stock price for Clearside Biomedical (NASDAQ: CLSD) is $1.17 last updated July 23, 2024 at 7:09 PM EDT.
There are no upcoming dividends for Clearside Biomedical.
Clearside Biomedical’s Q2 earnings are confirmed for Monday, August 12, 2024.
There is no upcoming split for Clearside Biomedical.
Clearside Biomedical is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.